Perspective
Our work in Perspective
-
Understanding the Bipartisan Senate Finance Prescription Drug Reform Package
“USC-Brookings Schaeffer Initiative experts unpack the bipartisan Senate Finance prescription drug reform package.
-
Who Would Have Believed it? Markets Can Reduce the ‘True’ Price of Cancer Drugs
When it comes to cancer, however, it is the price of health — not the price of drugs — that matters. As we think about ways to wring value out of the health care system, we acknowledge that CMS reforms and markets seem to be working in therapeutic areas with rapid innovation.
Categorized in -
California Saw Reduction in Out-of-Network Care from Affected Specialties after 2017 Surprise Billing Law
This blog presents new evidence on observed changes in provider network breadth after the implementation of California’s 2017 law.
-
Where Does Your State Stand in Texas vs. U.S.?
In Texas v. U.S., Texas and a number of other states have sued the federal government, arguing that the entire ACA should be struck down. So, where does your state stand in Texas v. U.S.?
Categorized in -
The Trump DOJ has Taken an Unexpected and Unworkable Position on the ACA
This piece describes the claim DOJ has made in regards to Texas v. U.S., attempts to unpack some of the complicated policy implications, and then considers the relevant legal issues.
Categorized in -
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
Experts lay out considerations for expanding the administration’s proposed model beyond Medicare Part B drugs.
Categorized in -
Why Your Employer-Sponsored Insurance May Ultimately Not Be Good For You
Nearly 160 million Americans get insurance through employers, but that does not mean it’s good social policy.
Categorized in -
Is This the Healthcare Policy Both Republicans and Democrats Can Agree On?
A mix of universal catastrophic coverage and private insurers would be cheaper than Medicare for All, Dana Goldman wrote in MarketWatch.
Categorized in -
What is Surprise Billing?
Experts from the USC-Brookings Schaeffer Initiative for Health Policy answer commonly asked questions about surprise medical bills and how to deal with them at a policy level.
Categorized in -
The Use of Vendors in Medicare Part B Drug Payment
USC-Brookings Schaeffer Initiative experts provide an analysis of a voluntary vendor approach for Medicare to restrain drug spending for Part B drugs.
Categorized in